Treatment with rituximab in benign and malignant hematologic disorders in children

MeSH terms

• Adolescent
• Adult
• Anemia, Hemolytic, Autoimmune / drug therapy
• Antibodies, Monoclonal / pharmacokinetics
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• B-Lymphocytes / drug effects
• B-Lymphocytes / metabolism
• Child
• Child, Preschool
• Drug Administration Schedule
• Drug Evaluation
• Female
• Hematologic Diseases / drug therapy*
• Hematologic Diseases / immunology
• Hemophilia A / drug therapy
• Humans
• Immunologic Factors / pharmacokinetics
• Immunologic Factors / therapeutic use*
• Infant
• Infusions, Intravenous
• Leukemia / drug therapy
• Lymphoma / drug therapy
• Lymphoproliferative Disorders / drug therapy
• Male
• Purpura, Thrombocytopenic, Idiopathic / drug therapy
• Rituximab
• Treatment Outcome